Market Cap
$5.1M
PHGE
Tessera Defense & Homeland Security Inc.
$0.3600 ▼ -6.44%
Prev close $0.3848Market cap$5.1M
12-mo target$304.00 (+51408.0%)
High Impact Filing (8/10) Biotech & Drug Discovery
Snapshot
The big-picture read on PHGE right now — valuation, ownership and activity at a glance.
Cap Size
Nano Cap
Inst. Holders
4 funds
Inst. Value
$9.2K
Inst. Activity
0 buys / 1 sells
Insider Activity
$0.00 buy / $33.3M sell
Insider Net $
-$33.3M
Social Sentiment
56° Neutral
SEC Reports
15
Press Releases
5
Price chart 30d -31.8%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
No data for this timeframe.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Sep 11, 2026 listing_status
Sep 1, 2026 SEC Delisted: PHGE — removed from the A symbol directory
BiomX Inc. Common Stock
BiomX Inc. (PHGE) announced a corporate name change to Tessera Defense and Homeland Security Inc., effective September 1
8-K — Impact 3/10
BiomX Inc. announced a 1-for-10 reverse stock split, approved by stockholders on August 25, 2026, effective September 9,
8-K — Impact 4/10
BiomX acquired a 10% stake in Motomea for $50,000 cash plus 1.3M restricted shares (pending NYSE approval), gaining acce
Impact 5/10
BiomX amended a $1.25M promissory note with Water.IO, extending maturity to November 1, 2026, and issuing 800,000 restri
Impact 7/10
BiomX Inc. amended a $1.25M promissory note with Water IO Ltd., extending the maturity from July 10, 2026 to November 1,
8-K — Impact 8/10
Jun 30, 2026 Inst.
JPMORGAN CHASE & CO — NEAR_EXIT
1,538 shares ($552.00)
Mar 31, 2026 Inst.
UBS Group AG — TRIM
573 shares ($2.2K)
Analyst ratings buy % -100.0%
How Wall Street rates the stock today, and the latest firm-by-firm actions.
Recent analyst actions
| Date | Firm | Action | Rating | Firm rating |
|---|---|---|---|---|
| Mar 9, 2026 | HC Wainwright & Co. | DOWNGRADE | Neutral | 43% |
| Nov 26, 2025 | HC Wainwright & Co. | REITERATE | Buy | 43% |
| Nov 25, 2025 | HC Wainwright & Co. | MAINTAIN | Buy | 43% |
| Aug 20, 2025 | HC Wainwright & Co. | REITERATE | Buy | 43% |
| May 16, 2025 | HC Wainwright & Co. | MAINTAIN | Buy | 43% |
| Apr 4, 2025 | HC Wainwright & Co. | REITERATE | Buy | 43% |
| Apr 1, 2025 | HC Wainwright & Co. | MAINTAIN | Buy | 43% |
| Jan 10, 2025 | HC Wainwright & Co. | REITERATE | Buy | 43% |
| Jan 8, 2025 | HC Wainwright & Co. | MAINTAIN | Buy | 43% |
| Aug 16, 2024 | HC Wainwright & Co. | REITERATE | Buy | 43% |
Monthly consensus history
| Period | Str. Buy | Buy | Hold | Sell | Str. Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | 0 | 0 | 3 | 1 | 2 | 0% | |
| Aug 1, 2026 | 0 | 0 | 3 | 1 | 2 | 0% | |
| Jul 1, 2026 | 2 | 4 | 2 | 0 | 0 | 75% | |
| Jun 1, 2026 | 2 | 4 | 2 | 0 | 0 | 75% | |
| May 1, 2026 | 2 | 4 | 2 | 0 | 0 | 75% | |
| Apr 1, 2026 | 2 | 4 | 2 | 0 | 0 | 75% | |
| Mar 1, 2026 | 2 | 5 | 1 | 0 | 0 | 88% | |
| Feb 1, 2026 | 2 | 5 | 1 | 0 | 0 | 88% |
Price targets
Where 1 covering analysts think PHGE trades over the next 12 months.
$304.00 +51408.0% upside Strong Buy
Current$0.5902 Low$304.00 Median$304.00 High$304.00 1 analysts
$304.00$304.00
Analyst rating None as of May 14, 2026
Social media sentiment mood +0.0%
Retail-investor mood aggregated across social media. 0° = very bearish, 100° = very bullish.
56°
Neutral
BearishNeutralBullish
Recent posts
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
15 SEC filing reports analyzed · 2 bullish, 5 bearish, 1 mixed, 7 neutral · avg impact 4.7/10.Plus 5 press releases.
NEUTRAL8-K3/10
BiomX Inc. (PHGE) announced a corporate name change to Tessera Defense and Homeland Security Inc., e
Sep 1, 2026
NEUTRAL8-K4/10
BiomX Inc. announced a 1-for-10 reverse stock split, approved by stockholders on August 25, 2026, ef
Aug 28, 2026
BEARISH8-K8/10
BiomX Inc. amended a $1.25M promissory note with Water IO Ltd., extending the maturity from July 10,
Jul 28, 2026
BEARISH424B57/10
BiomX Inc. filed a prospectus supplement to its existing ATM offering agreement with H.C. Wainwright
Jul 27, 2026
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Sep 11, 2026
listing_status
Delisted: PHGE — removed from the A symbol directory
BiomX Inc. Common Stock
Sep 4, 2026
other
BiomX: Zorronet Launches No-Code Control Over AI-Powered Autonomous Response Workflows
New capability lets operational teams connect existing cameras, sensors and physical systems into site-specific response logic - and change it on scre
Sep 4, 2026
short_volume
Short Volume: PHGE — 55.5% short (0.6M / 1.0M)
Short: 577,633 | Exempt: 6,368 | TRF Vol: 1,041,638 | Short Ratio: 55.5% | Off-exchange volume (dark pool + OTC)
Sep 1, 2026
short_volume
Short Volume: PHGE — 69.9% short (2.0M / 2.9M)
Short: 2,028,466 | Exempt: 45,202 | TRF Vol: 2,900,877 | Short Ratio: 69.9% | Off-exchange volume (dark pool + OTC)
Aug 14, 2026
other
BiomX Subsidiary Zorronet Receives Approximately $300,000 Purchase Order to Build Unified Operational Environment at Defense Technology Test and Evaluation Site
BiomX Subsidiary Zorronet Receives Approximately $300,000 Purchase Order to Build Unified Operational Environment at Defense Technology Test and Evalu
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
| Period | EPS Est. | Range | Growth | 30d Rev | Up/Dn | Revenue | # |
|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00–$0.00 | — | — | — | $0.0B | — |
| Next Q | $0.00 | $0.00–$0.00 | — | — | — | $0.0B | — |
| Current FY | $0.00 | $0.00–$0.00 | — | — | — | $0.0B | — |
| Next FY | $0.00 | $0.00–$0.00 | — | — | — | $0.0B | — |
Institutional ownership
Which big funds own PHGE (from quarterly 13F filings) and who is adding or trimming.
4 institutional holders with $9.2K total value (26,269 shares) as of 2026-Q2. Top holders: DANSKE, COMMONWEALTH, JPMORGAN. Net selling activity: 1 institutions trimmed/exited vs 0 added.
Top holders — 2026-Q2
| Fund | Shares | Value | % Tracked | Last move |
|---|---|---|---|---|
| DANSKE BANK A/S | 1 | $0.00 | 0.0% | — |
| COMMONWEALTH EQUITY SERVICES, LLC | 23,414 | $8.1K | 89.0% | — |
| JPMORGAN CHASE & CO | 1,538 | $552.00 | 6.0% | NEAR_EXIT -89.1% |
| BARCLAYS PLC | 1,316 | $458.00 | 5.0% | — |
Recent position changes
| Fund | Action | Prev | Current | Change | Value |
|---|---|---|---|---|---|
| JPMORGAN CHASE & CO | NEAR_EXIT | 14,135 | 1,538 | -89.1% | $552.00 |
| UBS Group AG | TRIM | 2,279 | 573 | -74.9% | $2.2K |
Insider activity
Buying and selling by company executives and directors (SEC Form 4).
1 insiders, 15 transactions. Net -$33.3M — $0.00 bought, $33.3M sold.
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Mar 17, 2026 | Yeganeh Reuven | Director | CONVERT | 530,000 | $2.00 | $1.1M |
| Mar 17, 2026 | Yeganeh Reuven | Director | SELL | 530,000 | $5.00 | $2.6M |
| Mar 17, 2026 | Yeganeh Reuven | Director | CONVERT | 1,060 | — | — |
| Mar 16, 2026 | Yeganeh Reuven | Director | SELL | 1,700,000 | $4.76 | $8.1M |
| Mar 16, 2026 | Yeganeh Reuven | Director | SELL | 2,000,000 | $5.24 | $10.5M |
| Mar 16, 2026 | Yeganeh Reuven | Director | CONVERT | 450,000 | $2.00 | $900.0K |
| Mar 16, 2026 | Yeganeh Reuven | Director | SELL | 450,000 | $5.00 | $2.3M |
| Mar 16, 2026 | Yeganeh Reuven | Director | CONVERT | 900 | — | — |
| Mar 16, 2026 | Yeganeh Reuven | Director | SELL | 1,300,000 | $5.00 | $6.5M |
| Mar 13, 2026 | Yeganeh Reuven | Director | SELL | 370,000 | $5.00 | $1.9M |
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for PHGE.
Shares short
623,734
Settlement Aug 31, 2026
Change vs prior
+83.3%
Semi-monthly cycle
Days to cover
1.0
At avg daily volume
Of shares outstanding
≈2.3%
Estimate — not % of float
All PHGE filing & press-release reports (20)
- 8-K reportSep 1, 2026
- 8-K reportAug 28, 2026
- PRESS-RELEASE reportAug 5, 2026
- PRESS-RELEASE reportJul 28, 2026
- 8-K reportJul 28, 2026
- 424B5 reportJul 27, 2026
- PRESS-RELEASE reportJul 8, 2026
- 8-K reportJul 2, 2026
- S-1 reportJun 29, 2026
- DEFA14A reportJun 23, 2026
- 8-K reportJun 18, 2026
- 424B5 reportJun 16, 2026
- 8-K reportJun 12, 2026
- 8-K reportMay 28, 2026
- 10-K/A reportApr 30, 2026
- 8-K reportApr 16, 2026
- 8-K reportApr 13, 2026
- PRESS-RELEASE reportApr 13, 2026
- 8-K reportApr 10, 2026
- PRESS-RELEASE reportApr 10, 2026